Clinigen Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
1,100
- Latest Deal Type
-
Debt Refin.
- Financing Rounds
-
6
- Investments
-
17
Clinigen General Information
Description
Manufacturer of pharmaceutical products and services intended to offer quicker access to new and critical medicines. The company operates in a range of areas of global medicine supply including clinical trials, unlicensed medicines and licensed medicines, enabling clients to deliver the right medicine to the right patient at the right time.
Contact Information
Website
www.clinigengroup.comCorporate Office
- Pitcairn House
- Crown Square, First Avenue
- Burton upon Trent DE14 2WW
- England, United Kingdom
Corporate Office
- Pitcairn House
- Crown Square, First Avenue
- Burton upon Trent DE14 2WW
- England, United Kingdom
Clinigen Timeline
Clinigen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Clinigen Comparisons
Industry
Financing
Details
Clinigen Competitors (1)
One of Clinigen’s competitors is Almac Group, a Corporation company based in Craigavon, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Almac Group | Corporation | Craigavon, United Kingdom |
Clinigen Patents
Clinigen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170145046-A1 | 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy | Inactive | 08-Feb-2005 | ||
| US-20190085017-A1 | 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy | Inactive | 08-Feb-2005 | ||
| CA-2596422-C | 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy | Active | 08-Feb-2005 | ||
| CA-2557857-A1 | Cancer treatment with topoisomerase-ii inhibitor, a bis-dioxypiperazine and radiation | Active | 02-Mar-2004 | ||
| CA-2557857-C | Cancer treatment with topoisomerase-ii inhibitor, a bis-dioxypiperazine and radiation | Active | 02-Mar-2004 | A61K31/496 |
Clinigen Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Clinigen Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Clinigen Investments & Acquisitions (17)
Clinigen’s most recent deal was a Buyout/LBO with Kinesys Consulting. The deal was made on 31-Jul-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Kinesys Consulting | 31-Jul-2024 | Buyout/LBO | Consulting Services (B2B) | ||
| Ascenian | 31-May-2024 | Buyout/LBO | Consulting Services (B2B) | ||
| Drug Safety Navigator | 29-Nov-2022 | Buyout/LBO | Practice Management (Healthcare) | ||
| iQone | 09-Oct-2018 | Merger/Acquisition | Pharmaceuticals | ||
| Clinical Supplies Management | 26-Sep-2018 | Merger/Acquisition | Logistics |
Clinigen Exits (4)
Clinigen’s most recent exit was on 09-Oct-2018 from iQone. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| iQone | 09-Oct-2018 | Completed |
|
||
| Proleukin | 02-Apr-2018 | Completed |
|
||
| Quantum Pharmaceutical | 01-Nov-2017 | Completed |
|
||
| Theravance (Commercialization rights to VIBATIV) | 11-Mar-2013 | Corporate Asset Purchase | Completed |
Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Kinesys Consulting | Glasgow, United Kingdom | 2007 | |
| International Medical Management | Tokyo, Japan | 2006 | |
| Link Healthcare | Warriewood, Australia | 1997 |
Clinigen FAQs
-
When was Clinigen founded?
Clinigen was founded in 2008.
-
Where is Clinigen headquartered?
Clinigen is headquartered in Burton upon Trent, United Kingdom.
-
What is the size of Clinigen?
Clinigen has 1,100 total employees.
-
What industry is Clinigen in?
Clinigen’s primary industry is Pharmaceuticals.
-
Is Clinigen a private or public company?
Clinigen is a Private company.
-
What is Clinigen’s current revenue?
The current revenue for Clinigen is .
-
How much funding has Clinigen raised over time?
Clinigen has raised $96M.
-
Who are Clinigen’s investors?
Triton Partners has invested in Clinigen.
-
Who are Clinigen’s competitors?
Almac Group is a competitor of Clinigen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
